Corbus Pharmaceuticals Reports 2018 First Quarter Financial Results and Provides Business Update
10 mai 2018 08h00 HE
|
Corbus Pharmaceuticals Holdings, Inc.
– Company continues to make consistent progress in the clinical development programs of lenabasum, in rare, chronic and serious inflammatory and fibrotic diseases – Norwood, MA, May 10, 2018 ...